Asciminib monotherapy in patients with chronic myeloid leukemia in chronic phase without BCR::ABL1T315I treated with at least 2 prior TKIs: Phase 1 final results - Hochhaus A; Kim DW; Cortes JE; Sasaki K; Mauro MJ; Hughes TP; Breccia M; Talpaz M; Minami H; Goh YT; DeAngelo DJ; Lang F; et al. (Leukemia, 2025)